Wells Fargo & Company Issues Positive Forecast for Insulet (NASDAQ:PODD) Stock Price
Insulet (NASDAQ:PODD – Get Free Report) had its target price upped by equities researchers at Wells Fargo & Company from $305.00 to $322.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price objective would […]
Insulet (NASDAQ:PODD – Get Free Report) had its target price upped by equities researchers at Wells Fargo & Company from $305.00 to $322.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price objective would […]
